# The role of the α7 nicotinic acetylcholine receptor in promoting M2 macrophage polarization at inflammatory sites

**Authors:** Taiki Mihara, Hiroshi Tanabe, Yuma Nonoshita, Yuki Yamakawa, Tamaki Kurosawa, Masatoshi Hori

PMC · DOI: 10.1038/s41598-026-35757-2 · Scientific Reports · 2026-01-14

## TL;DR

This study shows that the α7 nicotinic acetylcholine receptor promotes M2 macrophage polarization during inflammation, which may help reduce inflammation.

## Contribution

The study reveals a novel role of α7nAChR in promoting M2 macrophage polarization in inflammatory conditions.

## Key findings

- α7nAChR deficiency reduces M2 macrophage proportions in peritoneal cell populations.
- PNU-282987 treatment increases M2 macrophage markers in human and mouse-derived macrophages.
- The spleen may be involved in α7nAChR-mediated M2 macrophage regulation.

## Abstract

The α7 nicotinic acetylcholine receptor (α7nAChR) on macrophages exerts anti-inflammatory effects by suppressing the JAK/STAT and NF-κB pathways. Although the role of α7nAChR in immunoregulatory mechanisms in “individual” macrophages is established, studies on α7nAChR in an “overall population” of macrophages, including M1/M2 polarity, remain limited. Therefore, we examined the role of α7nAChR in M1/M2 polarity in inflammation. We generated peritonitis mouse models via LPS treatment and sterile intestinal manipulation in wild-type and α7nAChR-deficient mice. M1/M2 macrophage polarization was measured using PCR and flow cytometry. THP-1 and human peripheral blood mononuclear cells (hPBMC)-derived monocytes were treated with the α7nAChR agonist PNU-282987 during differentiation into M1/M2 macrophages. α7nAChR deficiency upregulated mRNA expression of the M1 marker and downregulated the M2 marker in a peritoneal cell population. Flow cytometry analysis revealed that the proportion of M2 macrophages in the peritoneal cell population decreased in α7nAChR-deficient mice in both models. In splenectomized LPS-treated wild-type mice, the proportion of M2 macrophages in the peritoneal cell population was reduced compared to that in sham-operated LPS-treated mice. The M2 marker CD206 and IL10 were upregulated in PNU-282987-treated THP-1 and hPBMC-derived macrophages. These results revealed that α7nAChR exerted M2-enhancing effects with the mechanism suggestively acting in the spleen.

The online version contains supplementary material available at 10.1038/s41598-026-35757-2.

## Linked entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], MRC1 (mannose receptor C-type 1) [NCBI Gene 4360], IL10 (interleukin 10) [NCBI Gene 3586]
- **Chemicals:** PNU-282987 (PubChem CID 11243536)
- **Species:** Mus musculus (taxon 10090), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, Cd68 (CD68 antigen) [NCBI Gene 12514] {aka Lamp4, Scard1, gp110}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, MRC1 (mannose receptor C-type 1) [NCBI Gene 4360] {aka CD206, CLEC13D, CLEC13DL, MMR, MRC1L1, bA541I19.1}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Arg1 (arginase, liver) [NCBI Gene 11846] {aka AI, Arg-1, PGIF}, ARG1 (arginase 1) [NCBI Gene 383], CD86 (CD86 molecule) [NCBI Gene 942] {aka B7-2, B7.2, B70, BU63, CD28LG2, CD86 v6}, Cd163 (CD163 antigen) [NCBI Gene 93671] {aka CD163v2, CD163v3}, Ccl1 (C-C motif chemokine ligand 1) [NCBI Gene 20290] {aka I-309, P500, Scya1, Tca-3, Tca3}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Mrc1 (mannose receptor, C type 1) [NCBI Gene 17533] {aka CD206, MR}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Chrna7 (cholinergic receptor, nicotinic, alpha polypeptide 7) [NCBI Gene 11441] {aka Acra7, alpha7, nAChR7, nAchR}, Cd80 (CD80 antigen) [NCBI Gene 12519] {aka B71, Cd28l, Ly-53, Ly53, MIC17, TSA1}, Itgax (integrin alpha X) [NCBI Gene 16411] {aka Cd11c, Cr4, N418}
- **Diseases:** IM (MESH:D007410), monocytic leukemia (MESH:D007951), trauma (MESH:D014947), hepatitis (MESH:D056486), pulmonary inflammation (MESH:D011014), septic shock (MESH:D012772), infectious inflammation (MESH:D007249), infection (MESH:D007239), rheumatoid arthritis (MESH:D001172), ulcerative colitis (MESH:D003093), infectious (MESH:D003141), Peritonitis (MESH:D010538), inflammatory bowel disease (MESH:D015212)
- **Chemicals:** Propidium iodide (MESH:D011419), streptomycin (MESH:D013307), penicillin (MESH:D010406), reactive oxygen species (MESH:D017382), Antisedan (MESH:C050701), PBS (MESH:D007854), LPS (MESH:D008070), water (MESH:D014867), isoflurane (MESH:D007530), noradrenaline (MESH:D009638), SYBR Green (MESH:C098022), HEPES (MESH:D006531), medetomidine (MESH:D020926), NO (MESH:D009614), PMA (MESH:D013755), PI (MESH:D010716), Acetylcholine (MESH:D000109), L-glutamine (MESH:D005973), C-28051 (-), midazolam (MESH:D008874), nicotine (MESH:D009538), butorphanol (MESH:D002077), PNU-282987 (MESH:C498513), peroxynitrite (MESH:D030421)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** FA — Homo sapiens (Human), Pancreatic adenocarcinoma, Cancer cell line (CVCL_4034), hPBMC — Sus scrofa (Pig), Spontaneously immortalized cell line (CVCL_6G31), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12880967/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12880967/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12880967/full.md

---
Source: https://tomesphere.com/paper/PMC12880967